EMEA-002117-PIP01-17-M01

Key facts

Active substance
Pevonedistat
Therapeutic area
Oncology
Decision number
P/0386/2019
PIP number
EMEA-002117-PIP01-17-M01
Pharmaceutical form(s)
Concentrate for solution for injection/infusion
Condition(s) / indication(s)
  • Treatment of acute myeloid leukaemia
  • Treatment of myelodysplastic syndromes
Route(s) of administration
Intravenous use
Contact for public enquiries
Takeda Pharma A/S

Tel. +44 020 31168000
E-mail: paediatrics@tgrd.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating